Artisan Partners Limited Partnership Veracyte, Inc. Transaction History

Artisan Partners Limited Partnership

$65 Billion
Q1 2024

A detailed history of Artisan Partners Limited Partnership transactions in Veracyte, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 3,079,863 shares of VCYT stock, worth $63.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,079,863

Previous 3,217,728 4.28%

Holding current value

$63.9 Million

Previous $88.5 Million 22.9%

% of portfolio

0.11%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.0 - $29.1 $2.9 Million - $4.01 Million	-137,865 Reduced 4.28%	3,079,863 $68.2 Million
Q4 2023 Feb 12, 2024	SELL	$19.72 - $28.68 $3.81 Million - $5.55 Million	-193,394 Reduced 5.67%	3,217,728 $88.5 Million
Q3 2023 Nov 09, 2023	SELL	$22.33 - $29.92 $2.99 Million - $4 Million	-133,700 Reduced 3.77%	3,411,122 $76.2 Million
Q2 2023 Aug 10, 2023	SELL	$20.96 - $26.99 $1.75 Million - $2.25 Million	-83,438 Reduced 2.3%	3,544,822 $90.3 Million
Q1 2023 May 11, 2023	SELL	$20.58 - $27.89 $2.73 Million - $3.7 Million	-132,771 Reduced 3.53%	3,628,260 $80.9 Million

Q4 2022 Feb 10, 2023	SELL	$15.31 - $29.94 $695,977 - $1.36 Million	-45,459 Reduced 1.19%	3,761,031 $89.2 Million
Q3 2022 Nov 10, 2022	SELL	$16.58 - $27.9 $579,454 - $975,077	-34,949 Reduced 0.91%	3,806,490 $63.2 Million
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $10.3 Million - $19.6 Million	-664,908 Reduced 14.75%	3,841,439 $76.4 Million
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $9.87 Million - $19.1 Million	-450,062 Reduced 9.08%	4,506,347 $124 Million
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $13.5 Million - $20.1 Million	-373,859 Reduced 7.01%	4,956,409 $204 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $11.6 Million - $17.2 Million	324,747 Added 6.49%	5,330,268 $248 Million
Q2 2021 Aug 12, 2021	BUY	$32.94 - $56.62 $10.3 Million - $17.8 Million	313,833 Added 6.69%	5,005,521 $200 Million
Q1 2021 May 11, 2021	BUY	$44.47 - $81.38 $51.7 Million - $94.6 Million	1,162,062 Added 32.92%	4,691,688 $252 Million
Q4 2020 Feb 10, 2021	BUY	$32.49 - $61.88 $2.83 Million - $5.39 Million	87,033 Added 2.53%	3,529,626 $173 Million
Q3 2020 Nov 12, 2020	SELL	$26.73 - $35.67 $309,346 - $412,808	-11,573 Reduced 0.34%	3,442,593 $112 Million
Q2 2020 Aug 12, 2020	BUY	$19.49 - $28.11 $14.6 Million - $21 Million	746,880 Added 27.59%	3,454,166 $89.5 Million
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $14 Million - $26.2 Million	869,678 Added 47.33%	2,707,286 $65.8 Million
Q4 2019 Feb 12, 2020	BUY	$20.78 - $29.99 $31.5 Million - $45.4 Million	1,514,044 Added 467.93%	1,837,608 $51.3 Million
Q3 2019 Nov 12, 2019	BUY	$23.87 - $30.93 $7.72 Million - $10 Million	323,564 New	323,564 $7.77 Million

Others Institutions Holding VCYT

# of Institutions

257

Shares Held

81.7M

Call Options Held

43K

Put Options Held

82K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.49B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.

Account

Artisan Partners Limited Partnership Veracyte, Inc. Transaction History